| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.20▼ | 9.27▼ | 9.27▼ | 9.18▼ | 8.60▲ |
| MA10 | 9.27▼ | 9.35▼ | 9.31▼ | 9.03▲ | 8.41▲ |
| MA20 | 9.31▼ | 9.29▼ | 9.18▼ | 8.54▲ | 8.20▲ |
| MA50 | 9.18▼ | 9.09▲ | 9.02▲ | 8.33▲ | 9.21▼ |
| MA100 | 9.11▲ | 8.79▲ | 8.52▲ | 8.14▲ | 10.70▼ |
| MA200 | 8.89▲ | 8.49▲ | 8.35▲ | 9.15▼ | 19.69▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.036▼ | -0.030▼ | -0.024▼ | 0.088▲ | 0.190▲ |
| RSI | 43.489▼ | 46.451▼ | 49.059▼ | 59.759▲ | 54.931▲ |
| STOCH | 12.387▼ | 47.641 | 53.018 | 78.110 | 60.448 |
| WILL %R | -100.000▼ | -68.000 | -68.000 | -36.957 | -30.972 |
| CCI | -112.957▼ | -106.342▼ | -123.510▼ | 79.333 | 210.580▲ |
|
Monday, June 29, 2026 04:47 AM
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the ...
|
|
Saturday, May 31, 2025 05:02 PM
Xilio Therapeutics, Inc. (NASDAQ:XLO) announced promising updated Phase 2 results for its investigational therapy vilastobart, combined with atezolizumab, in heavily pre-treated patients with ...
|
|
Thursday, September 12, 2024 05:00 PM
WALTHAM, MA - Xilio Therapeutics, Inc., a biopharmaceutical company, received a deficiency notice from the Nasdaq Stock Market on ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/26 | 9.18 | 9.35 | 9.125 | 9.125 | 14,870 |
| 30/06/26 | 9.27 | 9.89 | 9.01 | 9.58 | 26,118 |
| 29/06/26 | 9.0155 | 9.54 | 8.885 | 9.27 | 155,510 |
| 26/06/26 | 8.5001 | 9.07 | 8.50 | 9.05 | 43,909 |
| 25/06/26 | 9.00 | 9.02 | 8.745 | 8.89 | 9,363 |
| 24/06/26 | 8.94 | 9.088 | 8.91 | 9.01 | 17,843 |
| 23/06/26 | 9.00 | 9.297 | 8.90 | 8.90 | 32,215 |
| 22/06/26 | 8.99 | 9.07 | 8.8301 | 8.94 | 26,141 |
| 18/06/26 | 8.69 | 9.215 | 7.82 | 8.79 | 56,519 |
| 17/06/26 | 8.31 | 8.88 | 8.28 | 8.75 | 99,203 |
|
|
||||
|
|
||||
|
|